β-Amyloid (42-1), human TFA

This product is the inactive reverse-sequence control peptide for amyloid-β (1-42), a key peptide implicated in Alzheimer's disease pathogenesis. It is widely utilized in both in vitro and in vivo studies, including the establishment of animal models, to serve as a critical negative control in Alzheimer's disease research.